StonvexLoading…
StonvexStonvexStonvexCore line items from FRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $341.08M | $1.28B | $942.93M | $620.68M |
Operating Income | $208.99M | $602.20M | $421.55M | $310.88M |
Net Income | $159.10M | $411.08M | $281.33M | $219.68M |
EPS (Diluted) | $1.81 | $4.68 | $3.20 | $2.51 |
Total Assets | $9.10B | $9.13B | $8.86B | $8.62B |
Total Liabilities | $5.53B | $5.63B | $5.40B | $5.12B |
Cash & Equivalents | $115.63M | $107.42M | $111.31M | $177.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 86.39M | 86.27M | 86.27M | 86.26M |